NEJM· Jonathan Barratt Robert M. Brenner Sean J. Barbour Kirk N. Campbell Tom Doan Necmi Eren Jürgen Floege Marshall W. Fordyce Vivekanand Jha Zeeshan Khawaja Beom Seok Kim Adrian Liew Bart Maes Atanu Pal Roberto Pecoits-Filho Richard K.S. Phoon Dana V. Rizk Hitoshi Suzuki Vladimír Tesař Hernán Trimarchi Xuelian Wei Lixi Yu Hong Zhang and Richard Lafayettethe ORIGIN Phase 3 Trial Investigators*·· 1 day agoScore59
Atacicept in IgA Nephropathy — Phase 3 Trial Final Efficacy Analysis
In brief
The New England Journal of Medicine has published online the final efficacy analysis of the phase 3 ORIGIN trial of atacicept in IgA nephropathy. The full detailed results remain to be reviewed.
Source: NEJM · nejm.org